Archive · 26 Jul 2026
Gland Pharma Stock: Analyst Predicts Rs 3,250 Target
A market expert named Pradeep Haldar has said that the stock of Gland Pharma, a big pharma company, looks good overall.
He thinks the stock might go up to Rs 3,250 in the next few months, even though there might be some small drops in the short term.
He advises investors to stay invested and be patient because the stock has the potential to do well in the long run.
Market expert Pradeep Haldar predicts Gland Pharma stock could reach Rs 3,250 in the medium term.
The stock's overall structure is considered good despite potential short-term corrections.
Investors are advised to maintain a medium-term holding period for optimal returns.
Near-term volatility is expected, but the stock is seen as structurally strong.
The prediction differentiates between structurally strong stocks and those with short-lived trading bounces.
- Who
- Pradeep Haldar, market expert
- What
- Predicted a price target of Rs 3,250 for Gland Pharma stock
- When
- Medium term (3 quarters)
- Where
- Pharmaceutical sector
- Why
- To provide investment advice and outlook for Gland Pharma stock
Optimistic View
Cautious View
Stock Performance
Optimistic View
The stock's overall structure looks good with potential for a rally to Rs 3,250 in the medium term.
Cautious View
Short-term correction is possible, indicating potential near-term volatility.
- Stock
- Gland Pharma
- Analyst
- Pradeep Haldar
- Price Target
- Rs 3,250
- Time Frame
- Medium term (3 quarters)
- Sector
- Pharmaceutical